These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21449693)

  • 21. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.
    Kalkanci A; Sugita T; Arikan S; Yucesoy M; Ener B; Otag F; Kiraz N; Kustimur S; Sancak B; Evci C; Emektas G
    Med Mycol; 2010 Feb; 48(1):141-6. PubMed ID: 19462333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phaeohyphomycosis and onychomycosis due to Chaetomium spp., including the first report of Chaetomium brasiliense infection.
    Hubka V; Mencl K; Skorepova M; Lyskova P; Zalabska E
    Med Mycol; 2011 Oct; 49(7):724-33. PubMed ID: 21466265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.
    Vitale RG; de Hoog GS; Schwarz P; Dannaoui E; Deng S; Machouart M; Voigt K; van de Sande WW; Dolatabadi S; Meis JF; Walther G
    J Clin Microbiol; 2012 Jan; 50(1):66-75. PubMed ID: 22075600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
    Chowdhary A; Randhawa HS; Singh V; Khan ZU; Ahmad S; Kathuria S; Roy P; Khanna G; Chandra J
    Med Mycol; 2011 Oct; 49(7):760-5. PubMed ID: 21395476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dark strain in the Fusarium solani species complex isolated from primary subcutaneous sporotrichioid lesions associated with traumatic inoculation via a rose bush thorn.
    Kantarcioglu AS; Summerbell RC; Sutton DA; Yücell A; Sarikaya E; Kaner G; Iscimen A; Altas K
    Med Mycol; 2010 Feb; 48(1):103-9. PubMed ID: 20055744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of antifungals against Zygomycetes.
    Alastruey-Izquierdo A; Castelli MV; Cuesta I; Zaragoza O; Monzón A; Mellado E; Rodríguez-Tudela JL
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():71-6. PubMed ID: 19754762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa.
    Garcia-Hermoso D; Hoinard D; Gantier JC; Grenouillet F; Dromer F; Dannaoui E
    J Clin Microbiol; 2009 Dec; 47(12):3862-70. PubMed ID: 19759217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia.
    Iwen PC; Freifeld AG; Sigler L; Tarantolo SR
    J Clin Microbiol; 2005 Nov; 43(11):5819-21. PubMed ID: 16272531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.
    Alastruey-Izquierdo A; Cuesta I; Houbraken J; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
    Med Mycol; 2010 Feb; 48(1):97-102. PubMed ID: 19296366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
    Perkhofer S; Locher M; Cuenca-Estrella M; Rüchel R; Würzner R; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2636-8. PubMed ID: 18458135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes.
    Ruan SY; Kuo YW; Huang CT; Hsiue HC; Hsueh PR
    Int J Antimicrob Agents; 2010 Jan; 35(1):85-8. PubMed ID: 19786341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.
    Spader TB; Venturini TP; Cavalheiro AS; Mahl CD; Mario DN; Lara VM; Santurio J; Alves SH
    Mycoses; 2011 Mar; 54(2):131-6. PubMed ID: 19780977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.